SCHOTT Pharma AG & Co. KGaA

DB:1SXP Stock Report

Market Cap: €4.1b

SCHOTT Pharma KGaA Balance Sheet Health

Financial Health criteria checks 5/6

SCHOTT Pharma KGaA has a total shareholder equity of €769.3M and total debt of €188.4M, which brings its debt-to-equity ratio to 24.5%. Its total assets and total liabilities are €1.4B and €629.7M respectively. SCHOTT Pharma KGaA's EBIT is €186.1M making its interest coverage ratio 41. It has cash and short-term investments of €22.2M.

Key information

24.5%

Debt to equity ratio

€188.40m

Debt

Interest coverage ratio41x
Cash€22.15m
Equity€769.31m
Total liabilities€629.73m
Total assets€1.40b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 1SXP's short term assets (€586.0M) exceed its short term liabilities (€415.6M).

Long Term Liabilities: 1SXP's short term assets (€586.0M) exceed its long term liabilities (€214.1M).


Debt to Equity History and Analysis

Debt Level: 1SXP's net debt to equity ratio (21.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 1SXP's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 1SXP's debt is well covered by operating cash flow (101.4%).

Interest Coverage: 1SXP's interest payments on its debt are well covered by EBIT (41x coverage).


Balance Sheet


Discover healthy companies